These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 8195945

  • 1. Trypanosoma cruzi affects nitric oxide production by murine peritoneal macrophages.
    Pakianathan DR, Kuhn RE.
    J Parasitol; 1994 Jun; 80(3):432-7. PubMed ID: 8195945
    [Abstract] [Full Text] [Related]

  • 2. Synergism between tumor necrosis factor-alpha and interferon-gamma on macrophage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide-dependent mechanism.
    Muñoz-Fernández MA, Fernández MA, Fresno M.
    Eur J Immunol; 1992 Feb; 22(2):301-7. PubMed ID: 1537373
    [Abstract] [Full Text] [Related]

  • 3. [TH1 response in the experimental infection with Trypanosoma cruzi].
    Cardoni RL, Antúnez MI, Abrami AA.
    Medicina (B Aires); 1999 Feb; 59 Suppl 2():84-90. PubMed ID: 10668248
    [Abstract] [Full Text] [Related]

  • 4. In vivo administration of recombinant IFN-gamma induces macrophage activation, and prevents acute disease, immune suppression, and death in experimental Trypanosoma cruzi infections.
    Reed SG.
    J Immunol; 1988 Jun 15; 140(12):4342-7. PubMed ID: 3131431
    [Abstract] [Full Text] [Related]

  • 5. Glycoconjugates isolated from Trypanosoma cruzi but not from Leishmania species membranes trigger nitric oxide synthesis as well as microbicidal activity in IFN-gamma-primed macrophages.
    Camargo MM, Andrade AC, Almeida IC, Travassos LR, Gazzinelli RT.
    J Immunol; 1997 Dec 15; 159(12):6131-9. PubMed ID: 9550414
    [Abstract] [Full Text] [Related]

  • 6. The microbicidal activity of interferon-gamma-treated macrophages against Trypanosoma cruzi involves an L-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-beta.
    Gazzinelli RT, Oswald IP, Hieny S, James SL, Sher A.
    Eur J Immunol; 1992 Oct 15; 22(10):2501-6. PubMed ID: 1396957
    [Abstract] [Full Text] [Related]

  • 7. Activation-induced T cell death exacerbates Trypanosoma cruzi replication in macrophages cocultured with CD4+ T lymphocytes from infected hosts.
    Nunes MP, Andrade RM, Lopes MF, DosReis GA.
    J Immunol; 1998 Feb 01; 160(3):1313-9. PubMed ID: 9570549
    [Abstract] [Full Text] [Related]

  • 8. Leishmania sp: comparative study with Toxoplasma gondii and Trypanosoma cruzi in their ability to initialize IL-12 and IFN-gamma synthesis.
    Oliveira MA, Santiago HC, Lisboa CR, Ceravollo IP, Trinchieri G, Gazzinelli RT, Vieira LQ.
    Exp Parasitol; 2000 Jun 01; 95(2):96-105. PubMed ID: 10910710
    [Abstract] [Full Text] [Related]

  • 9. Trypanosoma cruzi: Tc52 released protein-induced increased expression of nitric oxide synthase and nitric oxide production by macrophages.
    Fernandez-Gomez R, Esteban S, Gomez-Corvera R, Zoulika K, Ouaissi A.
    J Immunol; 1998 Apr 01; 160(7):3471-9. PubMed ID: 9531308
    [Abstract] [Full Text] [Related]

  • 10. Cytokine and nitric oxide regulation of the immunosuppression in Trypanosoma cruzi infection.
    Abrahamsohn IA, Coffman RL.
    J Immunol; 1995 Oct 15; 155(8):3955-63. PubMed ID: 7561103
    [Abstract] [Full Text] [Related]

  • 11. IL-10 mediates susceptibility to Trypanosoma cruzi infection.
    Reed SG, Brownell CE, Russo DM, Silva JS, Grabstein KH, Morrissey PJ.
    J Immunol; 1994 Oct 01; 153(7):3135-40. PubMed ID: 8089491
    [Abstract] [Full Text] [Related]

  • 12. [Role of cytokines in resistance and pathology in Trypanosoma cruzi infection].
    Laucella SA, Rottenberg ME, de Titto EH.
    Rev Argent Microbiol; 1996 Oct 01; 28(2):99-109. PubMed ID: 8768488
    [Abstract] [Full Text] [Related]

  • 13. Regulatory role of Toll-like receptor 2 during infection with Trypanosoma cruzi.
    Ropert C, Gazzinelli RT.
    J Endotoxin Res; 2004 Oct 01; 10(6):425-30. PubMed ID: 15588426
    [Abstract] [Full Text] [Related]

  • 14. Synergistic protection by specific antibodies and interferon against infection by Trypanosoma cruzi in vitro.
    Plata F, Wietzerbin J, Pons FG, Falcoff E, Eisen H.
    Eur J Immunol; 1984 Oct 01; 14(10):930-5. PubMed ID: 6208038
    [Abstract] [Full Text] [Related]

  • 15. Deficient control of Trypanosoma cruzi infection in C57BL/6 mice is related to a delayed specific IgG response and increased macrophage production of pro-inflammatory cytokines.
    Pérez AR, Tamae-Kakazu M, Pascutti MF, Roggero E, Serra E, Revelli S, Bottasso O.
    Life Sci; 2005 Sep 02; 77(16):1945-59. PubMed ID: 15916779
    [Abstract] [Full Text] [Related]

  • 16. AgC10, a mucin from Trypanosoma cruzi, destabilizes TNF and cyclooxygenase-2 mRNA by inhibiting mitogen-activated protein kinase p38.
    Alcaide P, Fresno M.
    Eur J Immunol; 2004 Jun 02; 34(6):1695-704. PubMed ID: 15162440
    [Abstract] [Full Text] [Related]

  • 17. Acute Trypanosoma cruzi infection: IL-12, IL-18, TNF, sTNFR and NO in T. rangeli-vaccinated mice.
    Basso B, Cervetta L, Moretti E, Carlier Y, Truyens C.
    Vaccine; 2004 May 07; 22(15-16):1868-72. PubMed ID: 15121297
    [Abstract] [Full Text] [Related]

  • 18. Intracellular co-localization of Trypanosoma cruzi and inducible nitric oxide synthase (iNOS): evidence for dual pathway of iNOS induction.
    Rottenberg ME, Castaños-Velez E, de Mesquita R, Laguardia OG, Biberfeld P, Orn A.
    Eur J Immunol; 1996 Dec 07; 26(12):3203-13. PubMed ID: 8977323
    [Abstract] [Full Text] [Related]

  • 19. Involvement of nitric oxide (NO) and TNF-alpha in the oxidative stress associated with anemia in experimental Trypanosoma cruzi infection.
    Malvezi AD, Cecchini R, de Souza F, Tadokoro CE, Rizzo LV, Pinge-Filho P.
    FEMS Immunol Med Microbiol; 2004 May 01; 41(1):69-77. PubMed ID: 15094169
    [Abstract] [Full Text] [Related]

  • 20. Macrophage activity, IL-6 levels, antibody response and heart histology in rats undergoing an attenuated Trypanosoma cruzi acute infection upon treatment with recombinant interferon gamma.
    Revelli S, Didoli G, Roggero E, Moreno H, Bernabo J, Wietzerbin J, Bottasso O.
    Cytokines Cell Mol Ther; 1998 Sep 01; 4(3):153-9. PubMed ID: 9825840
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.